—

Saturn V Capital Management LP

Q4 2025 13F Holdings

  • Location
    austin, TX
  • Num holdings

    20

  • Value ($000)

    $544,901

  • Date Filed
    02/17/2026
  • Form type
    13F-HR
  • CIK
    0001964437
  • All SEC filings
  • Note
    Holdings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q4 2025 to
Select Quarter
Issuer Name
Class
CUSIP
VALUE
%
Shares
Principal
Option Type
---

ABIVAX SA

SPONSORED ADS
00370M103
$87.55M
16 %

649,179

A
AMLX

AMYLYX PHARMACEUTICALS INC

COM
03237H101
$54.32M
10 %

4,496,487

C
COGT

COGENT BIOSCIENCES INC

COM
19240Q201
$43.23M
8 %

1,217,064

---

JAZZ PHARMACEUTICALS PLC

SHS USD
G50871105
$42.17M
8 %

248,070

P
PCVX

VAXCYTE INC

COM
92243G108
$36.86M
7 %

798,940

D
DYN

DYNE THERAPEUTICS INC

COM
26818M108
$34.99M
6 %

1,788,616

---

PHARVARIS N V

COM
N69605108
$31.64M
6 %

1,140,033

C
CELC

CELCUITY INC

COM
15102K100
$31.63M
6 %

317,095

A
ALMS

ALUMIS INC

COM
022307102
$30.61M
6 %

3,135,953

I
IRON

DISC MEDICINE INC

COM
254604101
$23.7M
4 %

298,429

Rows Per Page
10
  • 5
  • 10
  • 20
  • 30
  • 50
  • 100
1 - 10 of 20